A Study of Apatinib in Recurrent or Recurrent High-grade Glioma

NCT03390062 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Glioma

Interventions

DRUG: Apatinib

Sponsor

West China Hospital

Collaborators

[object Object]